239 related articles for article (PubMed ID: 29848209)
1. Neutrophil-lymphocyte ratio is a marker of survival and cardiac complications rather than patency following revascularization of lower extremities.
Pourafkari L; Choi C; Garajehdaghi R; Tajlil A; Dosluoglu HH; Nader ND
Vasc Med; 2018 Oct; 23(5):437-444. PubMed ID: 29848209
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-lymphocyte ratio predicts disease severity and outcome after lower extremity procedures.
Bath J; Smith JB; Kruse RL; Vogel TR
J Vasc Surg; 2020 Aug; 72(2):622-631. PubMed ID: 31882318
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of an elevated neutrophil-lymphocyte ratio in the amputation-free survival of patients with chronic critical limb ischemia.
González-Fajardo JA; Brizuela-Sanz JA; Aguirre-Gervás B; Merino-Díaz B; Del Río-Solá L; Martín-Pedrosa M; Vaquero-Puerta C
Ann Vasc Surg; 2014 May; 28(4):999-1004. PubMed ID: 24559786
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study.
Azab B; Chainani V; Shah N; McGinn JT
Angiology; 2013 Aug; 64(6):456-65. PubMed ID: 22904109
[TBL] [Abstract][Full Text] [Related]
5. Relationship between neutrophil-lymphocyte ratio and severity of lower extremity peripheral artery disease.
Teperman J; Carruthers D; Guo Y; Barnett MP; Harris AA; Sedlis SP; Pillinger M; Babaev A; Staniloae C; Attubato M; Shah B
Int J Cardiol; 2017 Feb; 228():201-204. PubMed ID: 27865186
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-To-Lymphocyte Ratio as a Predictive Tool for Post-Operative Outcomes in Patients Undergoing Open Lower Extremity Revascularization Procedures.
Adler LSF; Rabie EM; Shave SM; Alla A; Rahimi SA; Beckerman WE
Ann Vasc Surg; 2022 Nov; 87():155-163. PubMed ID: 35817380
[TBL] [Abstract][Full Text] [Related]
7. Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
Atherosclerosis; 2017 Oct; 265():35-40. PubMed ID: 28843126
[TBL] [Abstract][Full Text] [Related]
8. The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia.
Arora P; Davari-Farid S; Pourafkari L; Gupta A; Dosluoglu HH; Nader ND
J Vasc Surg; 2015 Mar; 61(3):720-7. PubMed ID: 25499712
[TBL] [Abstract][Full Text] [Related]
9. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
[TBL] [Abstract][Full Text] [Related]
10. The effect of congestive heart failure on perioperative outcomes in patients undergoing lower extremity revascularization.
Amdur RL; Ashby B; Neville R; Tunstall A; Nguyen BN; Sidawy A
J Vasc Surg; 2016 May; 63(5):1289-95. PubMed ID: 27109795
[TBL] [Abstract][Full Text] [Related]
11. Alternative conduit for infrageniculate bypass in patients with critical limb ischemia.
Moreira CC; Leung AD; Farber A; Rybin D; Doros G; Siracuse JJ; Kalish J; Eslami MH
J Vasc Surg; 2016 Jul; 64(1):131-139.e1. PubMed ID: 27345506
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention.
Pereg D; Elis A; Neuman Y; Mosseri M; Segev D; Granek-Catarivas M; Lishner M; Hermoni D
Coron Artery Dis; 2014 Jan; 25(1):79-82. PubMed ID: 24128887
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage.
Giede-Jeppe A; Bobinger T; Gerner ST; Sembill JA; Sprügel MI; Beuscher VD; Lücking H; Hoelter P; Kuramatsu JB; Huttner HB
Cerebrovasc Dis; 2017; 44(1-2):26-34. PubMed ID: 28419988
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography.
Arbel Y; Finkelstein A; Halkin A; Birati EY; Revivo M; Zuzut M; Shevach A; Berliner S; Herz I; Keren G; Banai S
Atherosclerosis; 2012 Dec; 225(2):456-60. PubMed ID: 23040448
[TBL] [Abstract][Full Text] [Related]
15. An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease.
Owens CD; Kim JM; Hevelone ND; Gasper WJ; Belkin M; Creager MA; Conte MS
J Vasc Surg; 2012 Sep; 56(3):686-95. PubMed ID: 22554422
[TBL] [Abstract][Full Text] [Related]
16. The neutrophil-to-lymphocyte ratio is associated with bare-metal stent restenosis in STEMI patients treated with primary PCI.
Bolca O; Güngör B; Özcan KS; Karadeniz FÖ; Sungur A; Köroğlu B; Bakhshyaliyev N; Yelgeç NS; Karataş B; İpek G; Yilmaz H; Öztürk R
Coron Artery Dis; 2015 Aug; 26(5):402-8. PubMed ID: 25919903
[TBL] [Abstract][Full Text] [Related]
17. Modified Frailty Index Can Be Used to Predict Adverse Outcomes and Mortality after Lower Extremity Bypass Surgery.
Ali TZ; Lehman EB; Aziz F
Ann Vasc Surg; 2018 Jan; 46():168-177. PubMed ID: 28739453
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of 30-day unplanned readmission after lower extremity bypass.
McPhee JT; Barshes NR; Ho KJ; Madenci A; Ozaki CK; Nguyen LL; Belkin M
J Vasc Surg; 2013 Apr; 57(4):955-62. PubMed ID: 23332242
[TBL] [Abstract][Full Text] [Related]
19. Contemporary comparison of aortofemoral bypass to alternative inflow procedures in the Veteran population.
McPhee JT; Madenci A; Raffetto J; Martin M; Gupta N
J Vasc Surg; 2016 Dec; 64(6):1660-1666. PubMed ID: 27462000
[TBL] [Abstract][Full Text] [Related]
20. Preoperative inflammatory status as a predictor of primary patency after femoropopliteal stent implantation.
Nakazawa KR; Wengerter SP; Power JR; Lookstein RA; Tadros RO; Ting W; Faries PL; Vouyouka AG
J Vasc Surg; 2017 Jul; 66(1):151-159. PubMed ID: 28259571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
